highly significantp < 0.0001
Authors observed highly significant, cumulative dose-dependent increased OR of incidence of both SLE and RA following treatment with SERM ( p < 0.0001) [ 26 ].
Authors observed highly significant, cumulative dose-dependent increased OR of incidence of both SLE and RA following treatment with SERM ( p < 0.0001) [ 26 ].